Related Experiment Videos
[Efficacy of bisphosphonates for bone pain control]
1Department of Breast Oncology, Tokyo Medical University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 20, 2007
Summary
Zoledronic acid, a bisphosphonate, effectively reduces bone pain in patients with malignant tumors and bone metastasis. This treatment improves quality of life by alleviating skeletal-related events.
Area of Science:
- Oncology
- Pharmacology
- Bone Metastasis Research
Context:
- Bone metastasis significantly impacts patient quality of life (QOL) through skeletal-related events (SREs).
- Bisphosphonates are a cornerstone therapy for managing bone metastases from malignant tumors.
Purpose:
- To evaluate the efficacy of zoledronic acid in managing bone pain associated with malignant tumors.
- To assess the impact of zoledronic acid on skeletal-related events and quality of life in patients with bone metastasis.
Summary:
- Zoledronic acid, a recommended bisphosphonate by the American Society of Clinical Oncology (ASCO), is utilized for bone metastasis treatment.
- Clinical trials demonstrate that zoledronic acid consistently reduces Brief Pain Inventory (BPI) composite pain scores compared to placebo.
- The study highlights the benefits of bisphosphonates, specifically zoledronic acid, in alleviating bone pain for patients experiencing bone metastasis.
Impact:
- Zoledronic acid offers significant pain relief for patients suffering from bone metastasis.
- Effective management of bone pain contributes to an improved quality of life for cancer patients.
- This research supports the established guidelines recommending bisphosphonates for skeletal-related events in metastatic bone disease.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:29Blood and Nerve Supply to the Bones
Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...